Radiolabeled Gamma-Aapeptides: A New Class of Pet Tracers
Hao Hong,Youhong Niu,Yunan Yang,Haifan Wu,Yin Zhang,Jonathan Engle,Todd Barnhart,Jianfeng Cai,Weibo Cai
2012-01-01
Journal of Nuclear Medicine
Abstract:1522 Objectives The goal of this study was to design, synthesize, and characterize 64Cu-labeled γ-AApeptides, a new class of peptidomimetics with superb stability, for positron emission tomography (PET) imaging applications. Methods A γ-AApeptide that mimics the tripeptide sequence RGD is termed γ-AA1, which was conjugated to DOTA via a linker and termed γ-AA2. Flow cytometry studies were performed in U87MG cancer cells (integrin αvβ3-positive) to evaluate the affinity of the γ-AApeptide-based conjugates for integrin αvβ3. γ-AA2 was labeled with 64Cu and the enzymatic stability of 64Cu-γ-AA2 was measured by radio HPLC. PET imaging, biodistribution, and blocking studies were performed on U87MG tumor-bearing mice to evaluate the in vivo tumor targeting efficacy of 64Cu-γ-AA2. Results γ-AA1 has similar binding affinity to integrin αvβ3 as the c(RGDyK) peptide. However, the enzymatic stability was much higher: 8% degradation of 64Cu-γ-AA2 and 100% degradation of 64Cu-labeled c(RGDyK) respectively after incubation with 0.1 mg/mL pronase at 37 °C for 2 h. Uptake of 64Cu-γ-AA2 in the U87MG tumor was clearly visible as early as 0.5 h p.i., which remained persistent over time (0.9±0.3, 1.0±0.2, 1.1±0.2, and 0.7±0.2 %ID/g at 0.5, 2, 4, and 24 h p.i., n = 3). 64Cu-γ-AA2 clears rapidly from the circulation and excellent tumor contrast was observed, with tumor/muscle ratio of 3.8±0.9, 4.8±1.8, 5.8±1.4, and 8.3±3.9 at 0.5 h, 2 h ,4 h, and 24 h p.i. respectively. Administering a blocking dose of c(RGDyK) significantly reduced the U87MG tumor uptake, thereby confirming in vivo target specificity of 64Cu-γ-AA2. Conclusions We report PET imaging of integrin αvβ3 with a 64Cu-labled γ-AApeptide-based RGD mimetic, which exhibited comparable integrin αvβ3 binding affinity as the c(RGDyK) peptide but significantly higher resistance to enzymatic degradation and better in vivo stability, despite its shorter sequence and linear nature. This study establishes γ-AApeptides as a novel class of enzymatically stable targeting ligands for molecular imaging applications